Finally, we have found relatively poor correlations between a small group of miR-24-2-5p-modulated transcripts (IL6ST, PEX10, CNNM4) and miR-24-2-5p expression levels in BC tissues from patients, suggesting that the gene expression of these transcripts at the primary site is likely subjected to the regulation of other regulatory pathways. The gene discussed is CNNM4; the disease is breast cancer.